Haemonetics | HAE - Current Assets


Haemonetics reported $834.88M in Current Assets for its fiscal quarter ending in March of 2026.





Current Assets Change Date
Baxter International USD 6.99B 142M Jun/2026
Becton, Dickinson and Co. USD 8.01B 1.18B Mar/2026
Boston Scientific USD 7.97B 712M Jun/2026
Cerus USD 174.38M 7.26M Dec/2025
Cooper Companies USD 2.3B 166M Mar/2026
Fresenius EUR 11.03B 1.03B Dec/2025
Fresenius Medical Care EUR 8.11B 209.55M Mar/2026
Globus Medical USD 2.2B 72.51M Mar/2026
Haemonetics USD 834.88M 108.8M Mar/2026
ICU Medical USD 1.21B 22.69M Mar/2026
Intuitive Surgical USD 12.33B 807.5M Jun/2026
Medtronic USD 24.07B 75M Dec/2025
Merit Medical Systems USD 1.11B 10.46M Jun/2026
Neogen USD 604.6M 14.6M Mar/2026
OraSure Technologies USD 240.78M 21.13M Mar/2026
Plus Therapeutics USD 18.03M 2.86M Mar/2026
Quidel USD 1.38B 70.3M Mar/2026
ResMed USD 4.06B 245.26M Mar/2026
STAAR Surgical USD 312.4M 853K Mar/2026
Steris USD 2.39B 108.4M Mar/2026
Stryker USD 14.42B 1.08B Jun/2026
Teleflex USD 1.86B 78.67M Mar/2026
Terumo JPY 861.04B 45.48B Mar/2026
Thermo Fisher Scientific USD 23.36B 1.05B Jun/2026
US Physical Therapy USD 139.11M 881K Mar/2026
Zimmer Biomet Holdings USD 4.96B 157.4M Mar/2026